Acquired Hemorrhagic Diathesis of Unknown Nature

C. F Borchgrevink; A Hellem; D Voss; B. A Waaler

doi:10.1055/s-0038-1654381

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1959; 03(02): 187-193
DOI: 10.1055/s-0038-1654381

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Acquired Hemorrhagic Diathesis of Unknown Nature

Autoren

C. F Borchgrevink

¹Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)
A Hellem

¹Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)
D Voss

¹Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)
B. A Waaler

¹Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)

Abstract

Summary

1) A case of a severe, acquired hemorrhagic diathesis, complicating a carcinoma of the stomach, is reported.

2) The only pathological hemostatic finding was a markedly prolonged bleeding time.

3) Platelets were normal; the capillaries seemed to be normal. There was no increased fibrinolysis, and no other defect in his clotting mechanism could be discovered.

4) The prolonged bleeding time was probably caused by a hitherto undescribed mechanism.

Volltext

Referenzen

References
1 Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path 1953; 6: 23
2 Borchgrevink C. F, Waaler B. A. The secondary bleeding time. A new method for the differentiation of hemorrhagic disorders. Acta med. scand 1958; 162: 361
3 Hellem A. Demonstration of a factor in blood influencing the adhesivity of platelets to foreign surfaces. Paper no. 313, 7th Congr Int. Soc. Haemat; Rome: 1958
4 Hjort P, Rapaport S. I, Owren P. A. A simple, specific one-stage prothrombin assay using Russell’s viper venom in cephalin suspension. J. Lab. clin. Med 1955; 46: 89
5 Hjort P, Stormorken H. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate. Scand. J. clin. Lab. Invest 1957; 9 29 Suppl 86
6 Nygaard K. K. A direct method of counting platelets in oxalated plasma. Proc. Mayo Clin 1933; 8: 365
7 Nilsson I. M, Blombäck M, Francken I. von: On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand 1957; 159: 35
8 Nilsson I. M, Blombäck M, Jorpes E, Blombäck B, Johansson S. v Willebrand’s disease and its correction with human plasma fraction 1–0. Acta med. scand 1957; 159: 179
9 Owren P. A, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest 1951; 3: 201
10 Stapp W. F. A one-stage method for the assay of antihemophilic factor B (AHF B). With a comment on the antihemophilic factor B (AHF B) concentration in phenyl-indanedione (PID) therapy. Scand. J. clin. Lab. Invest 1958; 10: 169
11 Stefanini M, Dameshek W. The hemorrhagic disorders. Grune & Stratton; New York: 1955: 368
12 Voss D. Untersuchungen zur Gerinnsel-retraction. Paper no. 346, 7th Congr Int. Soc. Haemat; Rome: 1958
13 Waaler B. A. Simultaneous contribution to the formation of thrombin by the intrinsic and extrinsic blood clotting systems. Scand. J. clin. Lab. Invest 1957; 9: 322
14 Waaler B. A. Contact activation of blood. Studies on a plasma factor formed on contact with glass and similar surfaces, and related to the intrinsic blood clotting system Oslo University Press; Oslo: 1959: 133
15 Waaler B. A. Assay of antihemophilic factor A (AHF A)(In press)